QTTB ▲ +7.7% - Q32 Bio Inc.
$QTTB - Q32 Bio Presents Results from Part B of the SIGNAL-AA Clinical Trial of Bempikibart in Alopecia Areata in a Late-Breaker at the European Academy of Dermatology and Venereology Congress 2026
30-SEP-2026 09:15 AM ET
Share this post
More filings for $QTTB
QTTB ▲ +8.3% - Q32 Bio Inc.Sep 28, 2026QTTB ▼ -0.5% - Q32 Bio Inc.Sep 21, 2026QTTB ▼ -2.6% - Q32 Bio Inc.Sep 1, 2026QTTB - Q32 Bio Inc. - SEC Filing Update (14-AUG-2026) | ThinkSabio - Stocks SimplifiedAug 14, 2026$QTTB SEC Filing Update (31-JUL-2026) | ThinkSabio - Stocks SimplifiedJul 31, 2026$QTTB SEC Filing Update (20-JUL-2026) | ThinkSabio - Stocks SimplifiedJul 21, 2026
View full $QTTB filing history →💬 Comments
Loading comments…
Leave a comment